Fiche société
Alexandra Marine and General Hospital
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications2liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| CJH1 (CLR4001)The purpose of this study is to assess the ability of CJH1 to increase the sensitivity of dopamine receptors and thereby reduce symptoms of Parkinson's Disease. | Parkinson | Phase 1 | Traitement symptomatique | Canada | À vérifier |
| CJH1 (CLR4001)The purpose of this study is to assess the ability of CJH1 to increase the sensitivity of dopamine receptors and thereby reduce symptoms of Parkinson's Disease. | Parkinson | Phase 1 | Traitement symptomatique | Canada | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| CJH1 (CLR4001) | Parkinson | Phase 1 | NCT01684475 | A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEASE | UNKNOWN |
Publications
2| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| CJH1 (CLR4001) | Expression, characterization, and genomic structure of carp JAK1 kinase gene. | DNA and cell biology | ||
| CJH1 (CLR4001) | Contributions of regularly and irregularly discharging vestibular-nerve inputs to the discharge of central vestibular neurons in the alert squirrel monkey. | Experimental brain research |